New heart device aims to cut stroke risk without lifelong blood thinners
NCT ID NCT07455539
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new device (LAmbre II) that closes a small pouch in the heart called the left atrial appendage in people with atrial fibrillation. The goal is to reduce the risk of stroke without needing long-term blood thinners. Ten participants will be followed for about a year to see if the device is safe and works well.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-VALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common blood thinner shield your brain from dementia?
- Heart procedure showdown: which imaging method is safer?
- Researchers fine-tune blood thinner dosing for chinese heart patients
- Heart procedure may stop bladder bleeding without blood thinners
- New study sets standard blood levels for stroke prevention drugs in chinese patients
- New heart plug could free AF patients from lifelong blood thinners